- Record: found
- Abstract: found
- Article: not found
Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.
Ian M Thompson
1 ,
Richard K Valicenti ,
Peter Albertsen ,
Brian J Davis ,
S Larry Goldenberg ,
Carol Hahn ,
Eric Klein ,
Jeff Michalski ,
Mack Roach ,
Oliver Sartor ,
J Stuart Wolf ,
Martha M Faraday
Aug 2013
3-dimensional conformal radiotherapy,
3D-CRT,
ADT,
ARO,
ART,
ASTRO,
AUA,
American Society for Radiation Oncology,
American Urological Association,
Arbeitsgemeinschaft Radiologische Onkologie,
CTCAE,
EBRT,
EORTC,
EPE,
European Organization for Research and Treatment of Cancer,
GI,
GU,
IMRT,
OS,
PIVOT,
PSA,
Prostate Cancer Versus Observation Trial,
QoL,
RCT,
RFS,
RP,
RT,
RTOG,
Radiation Therapy Oncology Group,
SRT,
SVI,
SWOG,
Southwest Oncology Group,
adjuvant radiotherapy,
androgen deprivation therapy,
bRFS,
biochemical recurrence-free survival,
common toxicity criteria adverse event,
external beam radiotherapy,
extraprostatic extension,
gastrointestinal,
genitourinary,
intensity-modulated radiotherapy,
overall survival,
postoperative period,
prostate specific antigen,
prostatectomy,
prostatic neoplasms,
quality of life,
radical prostatectomy,
radiotherapy,
randomized controlled trial,
recurrence-free survival,
salvage radiotherapy,
seminal vesicle invasion
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The purpose of this guideline is to provide a clinical framework for the use of radiotherapy after radical prostatectomy as adjuvant or salvage therapy.
Related collections
Author and article information
3-dimensional conformal radiotherapy,3D-CRT,ADT,ARO,ART,ASTRO,AUA,American Society for Radiation Oncology,American Urological Association,Arbeitsgemeinschaft Radiologische Onkologie,CTCAE,EBRT,EORTC,EPE,European Organization for Research and Treatment of Cancer,GI,GU,IMRT,OS,PIVOT,PSA,Prostate Cancer Versus Observation Trial,QoL,RCT,RFS,RP,RT,RTOG,Radiation Therapy Oncology Group,SRT,SVI,SWOG,Southwest Oncology Group,adjuvant radiotherapy,androgen deprivation therapy,bRFS,biochemical recurrence-free survival,common toxicity criteria adverse event,external beam radiotherapy,extraprostatic extension,gastrointestinal,genitourinary,intensity-modulated radiotherapy,overall survival,postoperative period,prostate specific antigen,prostatectomy,prostatic neoplasms,quality of life,radical prostatectomy,radiotherapy,randomized controlled trial,recurrence-free survival,salvage radiotherapy,seminal vesicle invasion
3-dimensional conformal radiotherapy, 3D-CRT, ADT, ARO, ART, ASTRO, AUA, American Society for Radiation Oncology, American Urological Association, Arbeitsgemeinschaft Radiologische Onkologie, CTCAE, EBRT, EORTC, EPE, European Organization for Research and Treatment of Cancer, GI, GU, IMRT, OS, PIVOT, PSA, Prostate Cancer Versus Observation Trial, QoL, RCT, RFS, RP, RT, RTOG, Radiation Therapy Oncology Group, SRT, SVI, SWOG, Southwest Oncology Group, adjuvant radiotherapy, androgen deprivation therapy, bRFS, biochemical recurrence-free survival, common toxicity criteria adverse event, external beam radiotherapy, extraprostatic extension, gastrointestinal, genitourinary, intensity-modulated radiotherapy, overall survival, postoperative period, prostate specific antigen, prostatectomy, prostatic neoplasms, quality of life, radical prostatectomy, radiotherapy, randomized controlled trial, recurrence-free survival, salvage radiotherapy, seminal vesicle invasion